Quarterly report [Sections 13 or 15(d)]

Revenue (Tables)

v3.25.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2025
Revenue Recognition [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
  Three Months Ended
March 31,
  2025 2024
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products $ 638  1.8  % $ 615  1.9  %
Third-Party Payer products 3,951  11.4  % 1,872  5.9  %
Patient Services revenue recognized over time:
Direct rental services 1,914  5.5  % 3,572  11.2  %
Third-Party Payer rental services 12,215  35.2  % 10,977  34.3  %
Total Patient Services accounted for under ASC 606 18,718  53.9  % 17,036  53.2  %
Device Solutions revenue recognized at a point in time:
Products 4,002  11.5  % 4,213  13.2  %
Services
 2,350  6.8  % 2,409  7.5  %
Device Solutions revenue recognized over time:
Services
 1,855  5.3  % 1,969  6.2  %
Total Device Solutions accounted for under ASC 606 8,207  23.6  % 8,591  26.9  %
Total Revenue Accounted for under ASC 606 26,925  77.6  % 25,627  80.1  %
Patient Services lease revenue
 2,056  5.9  % 1,555  4.9  %
Device Solutions lease revenue
 5,735  16.5  % 4,813  15.0  %
Total Revenue accounted for under ASC 842, Leases 7,791  22.4  % 6,368  19.9  %
Total Net Revenue $ 34,716  100.0  % $ 31,995 100.0  %
Schedule of Accounts, Notes, Loans and Financing Receivable
(dollars in thousands)
As of March 31, 2025
As of December 31, 2024
 $ Change
Accounts receivable, net $ 23,892  $ 21,155  $ 2,737 
Contract assets $ 714  $ 570  $ 144 
Contract liabilities $ 25  $ —  $ 25